Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"Combination Particles"”.

  1. Analytical methods to determine the degree of drug association for complex injectable drug-combination particles containing multiple drug substances

    … a complex injectable LPV/RTV/TFV in a drug-combination nanoparticle (DcNP) product candidate, referred to as targeted long-acting combination antiretroviral therapy 101 (TLC-ART 101) that is currently under clinical testing. A next generation product, TLC-ART 301 composed of DTG, 3TC and TFV …

    washington Repository record for Analytical methods to determine the degree of drug association for complex injectable drug-combination particles containing multiple drug substances (opens in a new tab)

  2. Investigation and Optimization of a Solvent / Anti-Solvent Crystallization Process for the Production of Inhalation Particles

    … used to deliver drugs to the lungs. The drug particles used in these DPIs should possess a number of key properties. These include an aerodynamic particle size < 5μm and particle crystallinity for long term formulation stability. The conventionally used micronization technique to produce …

    vcu Repository record for Investigation and Optimization of a Solvent / Anti-Solvent Crystallization Process for the Production of Inhalation Particles (opens in a new tab)

  3. Engineering of Inhalation Aerosols Combining Theophylline and Budesonide

    … This type of particle has the advantage over a combination product containing both drugs in a physical mixture which occurs rather randomly deposition leading to API segregation and non-dose-uniformity. Dry powder inhalers (DPIs) is a type of therapeutic pharmaceutical formulations usually …

    bradford Repository record for Engineering of Inhalation Aerosols Combining Theophylline and Budesonide (opens in a new tab)

  4. Drug combination nanoparticles targeted to ICAM-1 on breast cancer cells enhance cellular drug exposure in vitro and in mouse model

    … proven to enable the assembly of potent drugs in combination to provide long-acting effects in the body. Specifically, this research assembled a highly potent two-drug combination of gemcitabine (G) and paclitaxel (T) into drug combination nanoparticles or DcNP. We then determined whether a cell …

    washington Repository record for Drug combination nanoparticles targeted to ICAM-1 on breast cancer cells enhance cellular drug exposure in vitro and in mouse model (opens in a new tab)